首页> 外文期刊>Der Pharmacia Lettre >Formulation and evaluation of self-emulsifying drug delivery system for BCS Class - II Drug
【24h】

Formulation and evaluation of self-emulsifying drug delivery system for BCS Class - II Drug

机译:BCS II类药物自乳化给药系统的制定与评估

获取原文
           

摘要

The oral route by so far, has always been the preferred route of drug delivery because it was the easiest and most convenient of non-invasive administration. But oral route possesses problems such as to poor bioavailability, hepatic metabolism, lack of dose proportionality.Therefore, developing suitable formulation for such active pharmaceutical ingredients (API) present a major challenge to pharmaceutical scientist. The purpose of study was to formulate solid self emulsifying drug delivery system containing Ketoprofen as sustain release dosage form. The aim of present research was to formulate Liquid SEDDS which contains the drug ketoprofen, oleic acid (oil), Tween 80 (surfactant) and Ethanol (Co-surfactant). The ratio of this component in this formulation was 22.50:25.8:51.6 9(w/w) and optimized by pseudo ternary diagram. The droplet size of optimized liquid with drug was 111.11nm and solid SEDDS 965nm. Silicon dioxide was used as adsorbent agent. The formulation was characterized for in-vitro studies. The work was aimed to increase dissolution rate as compared to other oral dosage forms.
机译:迄今为止,口服途径一直是药物递送的首选途径,因为它是最简单,最方便的非侵入性给药方式。但是口服途径存在生物利用度差,肝脏代谢新陈代谢,剂量比例不足等问题。因此,开发适用于这种活性药物成分(API)的制剂对药物科学家构成了重大挑战。研究的目的是配制以酮洛芬为缓释剂型的固体自乳化药物递送系统。本研究的目的是配制包含药物酮洛芬,油酸(油),吐温80(表面活性剂)和乙醇(助表面活性剂)的液体SEDDS。该成分在该配方中的比例为22.50:25.8:51.6 9(w / w),并通过伪三元图进行了优化。药物优化液体的液滴尺寸为111.11nm,固体SEDDS为965nm。二氧化硅用作吸附剂。将该制剂表征用于体外研究。与其他口服剂型相比,该工作旨在提高溶出度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号